PMID- 8790307
OWN - NLM
STAT- MEDLINE
DCOM- 19961010
LR  - 20190702
IS  - 0038-4348 (Print)
IS  - 0038-4348 (Linking)
VI  - 89
IP  - 9
DP  - 1996 Sep
TI  - Allogeneic bone marrow transplantation.
PG  - 857-68
AB  - Allogeneic bone marrow transplantation (BMT) after high-dose, marrow-ablative 
      chemoradiotherapy has been established as the treatment of choice for various 
      hematologic, neoplastic, and congenital disorders. The most common type of marrow 
      graft is an allogeneic one from a sibling donor who has compatible human 
      leukocyte antigen (HLA). Only 30% of patients requiring allogeneic BMT have an 
      HLA-compatible sibling donor. Over the past few years, marrows from unrelated 
      HLA-compatible donors have been used with increasing frequency and promising 
      outcome in certain hematologic malignancies. Despite the morbidity and mortality 
      associated with this treatment modality, allogeneic BMT may provide a 20% to 90% 
      chance of long-term, disease-free survival to patients with a wide variety of 
      neoplastic and abnormal marrow disorders.
FAU - Tabbara, I A
AU  - Tabbara IA
AD  - Bone Marrow Transplant Program, George Washington University School of Medicine, 
      Washington, DC 20037, USA.
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - South Med J
JT  - Southern medical journal
JID - 0404522
RN  - 0 (HLA Antigens)
SB  - IM
MH  - Bone Marrow/drug effects/radiation effects
MH  - Bone Marrow Diseases/therapy
MH  - Bone Marrow Purging/methods
MH  - Bone Marrow Transplantation/adverse effects/*methods
MH  - Disease-Free Survival
MH  - HLA Antigens/genetics
MH  - Hematologic Diseases/therapy
MH  - Histocompatibility
MH  - Humans
MH  - Neoplasms/therapy
MH  - Transplantation, Homologous
MH  - Treatment Outcome
RF  - 113
EDAT- 1996/09/01 00:00
MHDA- 1996/09/01 00:01
CRDT- 1996/09/01 00:00
PHST- 1996/09/01 00:00 [pubmed]
PHST- 1996/09/01 00:01 [medline]
PHST- 1996/09/01 00:00 [entrez]
AID - 10.1097/00007611-199609000-00003 [doi]
PST - ppublish
SO  - South Med J. 1996 Sep;89(9):857-68. doi: 10.1097/00007611-199609000-00003.